REFILE-J&J decides not to conduct trials in India for its COVID-19 vaccine - ET

(Corrects to remove extraneous words in first paragraph)

June 29 (Reuters) - Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India, the Economic Times reported on Tuesday, citing a company spokesperson.

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the report. (

The company is exploring how to accelerate the availability of its vaccine in India, the Economic Times said.

J&J did not immediately respond to a Reuters request for comment. (Reporting by Juby Babu in Bengaluru; Editing by Shounak Dasgupta)